<?xml version="1.0" encoding="UTF-8"?>
<p id="Par24" class="p">Antibiotic resistance has existed since the beginning of the antibiotic era. The increase in the frequency of drug resistant and invasive bacteria, a reduction in the development and approval of new drugs and projections of an imminent post antibiotic era threaten human health worldwide. Current practices of Intrapartum Antibiotic prophylaxis (IAP) against 
 <italic class="italic">S. agalactiae</italic> involve the administration of β-lactam antibiotics penicillin and ampicillin. The alternatives to penicillin include: cefazolin, clindamycin, erythromycin and vancomycin however, these alternative drugs have not been assessed in clinical trials and data on their concentration levels in amniotic fluid, foetal blood and tissue are limited [
 <xref ref-type="bibr" rid="CR1" class="xref">1</xref>, 
 <xref ref-type="bibr" rid="CR2" class="xref">2</xref>].
</p>
